Lymphomas in patients with Sjögren's syndrome: review of the literature and physiopathologic hypothesis.
about
HCV infection enhances Th17 commitment, which could affect the pathogenesis of autoimmune diseases.Cancer complicating systemic lupus erythematosus--a dichotomy emerging from a nested case-control study.Clinical, immunologic, and molecular factors predicting lymphoma development in Sjogren's syndrome patients.Lymphoproliferation in autoimmunity and Sjögren's syndrome.Rare case of Primary Pulmonary Extranodal Non-Hodgkin's Lymphoma in a Patient with Sjogren's Syndrome: Role of FDG-PET/CT in the Initial Staging and Evaluating Response to Treatment.Clonality analysis of lymphoproliferative disorders in patients with Sjögren's syndrome.Cytokines in Sjögren's syndrome.Predicting progression to lymphoma in Sjögren's syndrome patients.Saliva-microbe interactions and salivary gland dysfunction.An international cohort study of cancer in systemic lupus erythematosus.Clinical manifestations of autoimmune disease-related non-Hodgkin lymphoma: a Korean single-center, retrospective clinical study.Nitric oxide donors induce large-scale deletion mutations in human lymphoblastoid cells: implications for mutations in T-lymphocytes from arthritis patients.Gastrointestinal disease in Sjogren's syndrome: related to food hypersensitivities.Most cases of primary salivary mucosa-associated lymphoid tissue lymphoma are associated either with Sjoegren syndrome or hepatitis C virus infection.Prevalence and pattern of antinuclear autoantibodies in 347 patients with non-Hodgkin's lymphoma.Potential involvement of subclinical Sjögren's syndrome in various lung diseases.
P2860
Q33721367-9CB0CFF9-919D-424B-8236-58ADF2C750F2Q33937936-E634133D-CCD9-4F36-B52B-DAEBD91F57C5Q34712157-4C9BD345-AAC2-40E2-A758-11610CE58E3FQ35553396-EEA22441-65B4-4B13-8D25-62087CDF8368Q36664666-5D88098A-F035-4367-82A0-EB3553446FBEQ36971937-2B0B4106-CD4B-402F-BB4D-7F729306546AQ37387713-6B7BD304-723A-46E3-9459-D7FC29F43D96Q38180823-1024FECF-8AEB-453B-8EAF-0B6B373EDE81Q38204888-BE8016BB-DD3A-4422-8AE9-2D3B6DFC03C6Q38474206-1530F92A-A99C-4319-9003-FDF5734F9670Q39626822-83001D8E-8FBA-412A-9D3C-D5F362F7C652Q40759531-E5DB3265-BDCA-4D30-ADDA-9F486749C5DBQ41885184-69031529-689A-4D13-906D-19C15645339DQ42985694-751F70AD-49F6-42CB-866C-3137795FB28FQ47604692-CE12E6DC-82AE-49D4-A4CC-0D15D988CC24Q47854646-19EA870D-B282-4D44-BA45-CAD765F374DD
P2860
Lymphomas in patients with Sjögren's syndrome: review of the literature and physiopathologic hypothesis.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Lymphomas in patients with Sjö ...... d physiopathologic hypothesis.
@ast
Lymphomas in patients with Sjö ...... d physiopathologic hypothesis.
@en
Lymphomas in patients with Sjö ...... d physiopathologic hypothesis.
@nl
type
label
Lymphomas in patients with Sjö ...... d physiopathologic hypothesis.
@ast
Lymphomas in patients with Sjö ...... d physiopathologic hypothesis.
@en
Lymphomas in patients with Sjö ...... d physiopathologic hypothesis.
@nl
prefLabel
Lymphomas in patients with Sjö ...... d physiopathologic hypothesis.
@ast
Lymphomas in patients with Sjö ...... d physiopathologic hypothesis.
@en
Lymphomas in patients with Sjö ...... d physiopathologic hypothesis.
@nl
P2860
P1433
P1476
Lymphomas in patients with Sjö ...... d physiopathologic hypothesis.
@en
P2093
Mariette X
P2860
P356
10.3109/10428199909093729
P577
1999-03-01T00:00:00Z